Skip to main content

Table 1 Major adverse clinical events at 12 months

From: The Proliferation REduction with Vascular ENergy Trial (PREVENT)

 

Radiotherapy

Control

 

Event

(n = 80)

(n = 25)

P value

MACE (death, MI, TLR)

13 (16%)

6 (24%)

ns

MACE (death, MI, TVR)

21 (26%)

8 (32%)

ns

Death

1 (1%)

0 (0%)

ns

MI

   

   Total

8 (10%)

1 (4%)

ns

   Q-wave

2 (3%)

0 (0%)

 

   non-Q-wave

6 (7%)

1 (4%)

 

TLR5 (6%)

6 (24%)

<0.05

 

TVR

17 (21%)

8 (32%)

ns

  1. MACE, major adverse clinical events; MI, myocardial infarction; TLR, target lesion revascularization; TVR, target vessel revascularization.